Search and Filter
Results per Page:
Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding
Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds
Study underscores need for increased investment in federally funded cancer clinical trials
Fred Hutch launches Atlas of Inspiring Hispanic/Latinx Scientists
Online atlas recognizes contributions of Hispanic and Latinx scientists
Fred Hutch expands South Lake Union campus with acquisition of 1165 Eastlake Avenue and joint venture partnership in 1201 and 1208 Eastlake Avenue
Investment will accelerate research and care, save more than $300 million in new construction costs
Michelle Seitz joins Fred Hutch Board of Directors
Founder and CEO of MeydenVest Partners brings deep business expertise to board
Fred Hutch Cancer Center clinicians recognized as Seattle Met Magazine’s 2024 Top Doctors
Over 80 physicians, physician assistants and nurse practitioners named in annual list
Fred Hutch Obliteride invites community to bike, walk, run and fundraise on Aug. 10
Record-breaking season unites thousands to raise money for cancer prevention, detection, treatment and cures
Fred Hutch launches new scientific training program for high school and middle school teachers
Partners in Science 2.0 to train science teachers alongside Fred Hutch researchers making leading-edge advances in cancer research
Fred Hutch announces eight recipients of 2024 Dr. Eddie Méndez Scholar Award
National award recognizes exceptional postdoctoral researchers from historically underrepresented groups in science
Active surveillance shown to be an effective management strategy for prostate cancer patients
Study evaluated long-term outcomes of using active surveillance instead of immediate treatment with surgery or radiation
Could a medicated foam make gene therapies more accessible?
In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications